Showing results (121-130 of 653) with videos related to

Sort By:
Pageof 66
Japanese Journal of Clinical Oncology|March 20, 2010
A comparison of multimodality treatment: two or four courses of paclitaxel plus cisplatin or S-1 plus cisplatin followed by surgery for locally advanced gastric cancer, a randomized Phase II trial (COMPASS)Takaki Yoshikawa, Akira Tsuburaya, Satoshi Morita, et al.
Surgical Endoscopy|June 30, 2010
Construct validity of the LapVR virtual-reality surgical simulatorNaoki Iwata, Michitaka Fujiwara, Yasuhiro Kodera, et al.
Surgery Today|March 24, 2006
Laparoscopic wedge resection for gastrointestinal stromal tumors of the stomach: initial experienceYoshinari Mochizuki, Yasuhiro Kodera, Michitaka Fujiwara, et al.
Scientific Reports|November 25, 2017
Prognostic Value of Long Non-Coding RNA HULC and MALAT1 Following the Curative Resection of Hepatocellular CarcinomaFuminori Sonohara, Yoshikuni Inokawa, Masamichi Hayashi, et al.
Hepato-Gastroenterology|September 21, 2002
Carcinoma of the hepatic hilus developing 21 years after biliary diversion for choledochal cyst: a case reportMasahiko Koike, Kenzo Yasui, Yasuhiro Shimizu, et al.
Anticancer Research|September 16, 2016
Correlation Between Poor Prognosis and Lower TPPP Gene Expression in Hepatocellular CarcinomaYoshikuni Inokawa, Fuminori Sonohara, Mitsuro Kanda, et al.
Asian Journal of Endoscopic Surgery|September 2, 2022
Preoperative indocyanine green fluorescence injection to accurately determine a proximal margin during robotic distal gastrectomyKoki Nakanishi, Chie Tanaka, Mitsuro Kanda, et al.
Annals of Surgical Oncology|September 20, 2022
Gamma-aminobutyric Acid Type A Receptor Subunit Delta as a Potential Therapeutic Target in Gastric CancerKoichi Sawaki, Mitsuro Kanda, Hayato Baba, et al.
Transgenic Research|July 14, 2010
GADD34 suppresses wound healing by upregulating expression of myosin IIAChie Tanaka, Sachiko Ito, Naomi Nishio, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 2, 2003
Identification of S100A2 as a target of the DeltaNp63 oncogenic pathwayKenji Hibi, Shin-ichi Fujitake, Tsunenobu Takase, et al.
Pageof 66